$AMRN Recent Headlines Dow industrials suffer worst drop

New Post Public Reply Private Reply Replies (0) Message Board

Jan 14, 2014 at 1:01 PM

$AMRN Recent Headlines

Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
6 gut checks before the stock market's opening bell 6:12 a.m. July 8, 2013 - Shawn Langlois
6 gut checks before the stock market's opening bell 6:55 a.m. March 27, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 7:05 a.m. Feb. 27, 2013 - Shawn Langlois
Friday’s big movers: Groupon soars on Google talk 4:38 p.m. Dec. 7, 2012 - Sue Chang
Amarin down 17% on risks tied to drug launch 8:00 a.m. Dec. 7, 2012 - Steve Gelsi
Amarin down 18% in premarket trades 7:41 a.m. Dec. 7, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 3:40 p.m. Oct. 10, 2012 - Sue Chang
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Amarin issues patent update on fish-oil drug 11:29 a.m. Sept. 5, 2012 - Val Brickates Kennedy
Amarin jumps 16% after business update 11:06 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin rallies 15% on business update 9:48 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Amarin falls 11% on insider stock-sale reports 11:12 a.m. July 31, 2012 - Val Brickates Kennedy
Amarin, AuthenTec active; advancers outpace decliners 4-1 on NYSE 11:45 a.m. July 27, 2012 - blogs.marketwatch.com
Amarin down 9% in wake of drug approval 9:08 a.m. July 27, 2012 - Val Brickates Kennedy
Amarin gets FDA approval for Vascepa 5:09 p.m. July 26, 2012 - Wallace Witkowski
Amarin: FDA OKs Vascepa for high triglycerides 4:46 p.m. July 26, 2012 - Wallace Witkowski
Amarin halted ahead of FDA decision deadline 2:13 p.m. July 26, 2012 - Val Brickates Kennedy
Amarin halted ahead of FDA decision deadline 2:04 p.m. July 26, 2012 - Val Brickates Kennedy

Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends 9:06 a.m. Jan. 13, 2014 - Seeking Alpha
Amarin Out, Intercept Pharma In At J.P. Morgan Healthcare Confab 11:35 a.m. Jan. 12, 2014 - TheStreet.com
While Amarin Continues To Go Rancid, Neptune Will Soar 8:34 a.m. Jan. 11, 2014 - Seeking Alpha
Stock Watch Friday, 10 January 2013: Mannkind Rallies, Sirius Should Satisfy 8:36 a.m. Jan. 10, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Small Cap BioPharmas With Near Term Catalysts 7:55 a.m. Jan. 3, 2014 - Seeking Alpha
AMRN January 10th Options Begin Trading 11:43 a.m. Jan. 2, 2014 - TheStreet.com
Chelsea: FDA Panel Meeting And Trading Strategies 4:34 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Amarin: 3 Things Shareholders Should Demand In 2014 12:13 a.m. Dec. 30, 2013 - Seeking Alpha
Update on Amarin's Vascepa - Analyst Blog 11:15 a.m. Dec. 27, 2013 - Zacks.com
7 Biotechnology Stocks to Sell Now 2:45 a.m. Dec. 25, 2013 - InvestorPlace.com
4 Biotech Stocks on the Move 1:14 p.m. Dec. 20, 2013 - Wall St. Cheat Sheet
FDA Delays Decision on Amarin's Vascepa Drug 11:46 a.m. Dec. 20, 2013 - benzinga.com
Amarin's Anchor Gamble Sends Stock Up 20% On 'No News' News 11:18 a.m. Dec. 20, 2013 - Seeking Alpha
FDA delays ruling on expanding use of Amarin's Vascepa; shares soar 7:25 a.m. Dec. 20, 2013 - Seeking Alpha
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 5:03 a.m. Dec. 20, 2013 - benzinga.com
Amarin – Why AMRN Stock Is Set to Open to Sweet 24% Gains 3:12 a.m. Dec. 20, 2013 - InvestorPlace.com
Interesting AMRN Call Options For December 27th 11:24 a.m. Dec. 19, 2013 - TheStreet.com
Amarin's Vascepa: Too Limited A Market Or FDA Blunder? 1:11 p.m. Dec. 18, 2013 - benzinga.com

Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer 8:00 a.m. Dec. 27, 2013 - PR Newswire
New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare 8:00 a.m. Dec. 25, 2013 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and of a Lead Plaintiff Deadline of January 3, 2014 3:29 p.m. Dec. 24, 2013 - PR Newswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Amarin Corporation plc of Upcoming Deadline 11:27 a.m. Dec. 20, 2013 - BusinessWire
Important Trend Analysis: Amarin Corporation plc, Corporation, Geron Corporation, 3D Systems Corporation 10:22 a.m. Dec. 20, 2013 - ACCESSWIRE
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed 6:00 a.m. Dec. 20, 2013 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Announces the Filing of a Class Action Lawsuit Against Amarin Corporation plc Expanding the Class Period to Include July 9, 2009 Through October 16, 2013 and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Amarin Corporation plc to Inquire About the Lead Plaintiff Position Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN 4:59 p.m. Dec. 19, 2013 - GlobeNewswire
Amarin Announces Leadership Changes 9:07 a.m. Dec. 16, 2013 - GlobeNewswire
Glancy Binkow & Goldberg Files Class Action Lawsuit Against Amarin Corporation 9:32 p.m. Dec. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014 6:27 p.m. Dec. 11, 2013 - GlobeNewswire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations 6:00 a.m. Dec. 2, 2013 - GlobeNewswire
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Amarin Corporation plc 9:32 p.m. Nov. 27, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN 4:56 p.m. Nov. 27, 2013 - PR Newswire
Kantrowitz, Goldhamer & Graifman, P.C. Files Class Action Suit Against Amarin Corporation plc 3:44 p.m. Nov. 27, 2013 - BusinessWire
AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation 8:47 a.m. Nov. 26, 2013 - PR Newswire
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Amarin Corporation plc 1:32 p.m. Nov. 22, 2013 - BusinessWire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Oil Markets Shift Focus: Pipelines Trump Drilling

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...